Gilead Sciences Inc banner

Gilead Sciences Inc
DUS:GIS

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
DUS:GIS
Watchlist
Price: 105.32 EUR -2.98% Market Closed
Market Cap: €131.2B

Wall St Price Targets

GIS Price Targets Summary
Gilead Sciences Inc

Wall Street analysts forecast GIS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GIS is 141.28 EUR with a low forecast of 107.82 EUR and a high forecast of 165.38 EUR.

Lowest Forecast
Price Target
107.82 EUR
2% Upside
Average Forecast
Price Target
141.28 EUR
34% Upside
Highest Forecast
Price Target
165.38 EUR
57% Upside
Gilead Sciences Inc Competitors:
Price Targets
AYTU
Aytu Biopharma Inc
335% Upside
CIGI
Colliers International Group Inc
11% Upside
FLEX
Flex Ltd
5% Upside
CASY
Caseys General Stores Inc
-9% Downside
RLMD
Relmada Therapeutics Inc
115% Upside

Revenue
Forecast

9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.

Gross Profit
Forecast

9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Gilead Sciences Inc

Operating Income
Forecast

8% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
8% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.

Pre-Tax Income
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Gilead Sciences Inc

Net Income
Forecast

10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GIS's stock price target?
Price Target
141.28 EUR

According to Wall Street analysts, the average 1-year price target for GIS is 141.28 EUR with a low forecast of 107.82 EUR and a high forecast of 165.38 EUR.

What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.

What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.

What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett